Heme oxygenase-1 attenuates acute pulmonary inflammation by decreasing the release of segmented neutrophils from the bone marrow

Am J Physiol Lung Cell Mol Physiol. 2014 Nov 1;307(9):L707-17. doi: 10.1152/ajplung.00145.2014. Epub 2014 Aug 29.

Abstract

Recruiting polymorphonuclear neutrophil granulocytes (PMNs) from circulation and bone marrow to the site of inflammation is one of the pivotal mechanisms of the innate immune system. During inflammation, the enzyme heme oxygenase 1 (HO-1) has been shown to reduce PMN migration. Although these effects have been described in various models, underlying mechanisms remain elusive. Recent studies revealed an influence of HO-1 on different cells of the bone marrow. We investigated the particular role of the bone marrow in terms of HO-1-dependent pulmonary inflammation. In a murine model of LPS inhalation, stimulation of HO-1 by cobalt (III) protoporphyrin-IX-chloride (CoPP) resulted in reduced segmented PMN migration into the alveolar space. In the CoPP group, segmented PMNs were also decreased intravascularly, and concordantly, mature and immature PMN populations were higher in the bone marrow. Inhibition of the enzyme by tin protoporphyrin-IX increased segmented and banded PMN migration into the bronchoalveolar lavage fluid with enhanced PMN release from the bone marrow and aggravated parameters of tissue inflammation. Oxidative burst activity was significantly higher in immature compared with mature PMNs. The chemokine stromal-derived factor-1 (SDF-1), which mediates homing of leukocytes into the bone marrow and is decreased in inflammation, was increased by CoPP. When SDF-1 was blocked by the specific antagonist AMD3100, HO-1 activation was no longer effective in curbing PMN trafficking to the inflamed lungs. In conclusion, we show evidence that the anti-inflammatory effects of HO-1 are largely mediated by inhibiting the release of segmented PMNs from the bone marrow rather than direct effects within the lung.

Keywords: cobalt (III) protoporphyrin-IX-chloride; heme oxygenase-1; neutrophil; polymorphonuclear neutrophil granulocytes; tin protoporphyrin-IX.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Administration, Inhalation
  • Animals
  • Benzylamines
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / immunology
  • Bone Marrow Cells / pathology
  • Bronchoalveolar Lavage Fluid / chemistry
  • Bronchoalveolar Lavage Fluid / immunology
  • Chemokine CXCL12 / antagonists & inhibitors
  • Chemokine CXCL12 / genetics
  • Chemokine CXCL12 / metabolism
  • Cyclams
  • Gene Expression Regulation
  • Heme Oxygenase-1 / genetics
  • Heme Oxygenase-1 / metabolism*
  • Heterocyclic Compounds / pharmacology
  • Immunity, Innate / drug effects
  • Lipopolysaccharides
  • Male
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Metalloporphyrins / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Neutrophil Infiltration / drug effects
  • Neutrophils / drug effects
  • Neutrophils / immunology*
  • Neutrophils / pathology
  • Pneumonia / chemically induced
  • Pneumonia / enzymology*
  • Pneumonia / immunology
  • Pneumonia / pathology
  • Protoporphyrins / pharmacology
  • Respiratory Burst / drug effects

Substances

  • Benzylamines
  • Chemokine CXCL12
  • Cxcl12 protein, mouse
  • Cyclams
  • Heterocyclic Compounds
  • Lipopolysaccharides
  • Membrane Proteins
  • Metalloporphyrins
  • Protoporphyrins
  • cobaltiprotoporphyrin
  • tin protoporphyrin IX
  • Heme Oxygenase-1
  • Hmox1 protein, mouse
  • plerixafor